Communiqués RaySearch Laboratories AB

Actions

RAY B

SE0000135485

Equipement et technologie médicale avancés

PEA

Temps réel estimé Cboe Europe Autres places de cotation 17:25:00 23/07/2026			Varia. 5j.	Varia. 1 janv.
164,75 ^SEK	-4,10 %		-7,58 %	-27,28 %

20/07	Swedbank Robur réduit sa participation dans Raysearch sous le seuil des 5 %	FW
17/07	Affärsvärlden adopte une recommandation neutre sur Raysearch après son avertissement sur résultats	FW

Communiqués

17/07	RaySearch to present automation, speed, and analytics advancements at AAPM 2026	AQ
16/07	Preliminary results for the second quarter of 2026	AQ
07/07	RaySearch releases RayCare v2026	AQ
03/07	Yonsei Cancer Center expands use of RayStation	AQ
01/07	RaySearch releases RayStation v2026	AQ
29/06	RayIntelligence v2026: Advancing oncology analytics	AQ
26/06	Utilization of authorization to acquire own shares	AQ
18/06	RaySearch enters the Vietnamese market	AQ
16/06	Utilization of authorization to acquire own shares	AQ
05/06	RaySearch to showcase new advances in particle therapy at PTCOG 64	AQ
28/05	RaySearch Laboratories : Transcript Q1 2021 (engelska)	PU
21/05	Antony Lomax joins RaySearch to strengthen leadership in particle therapy	AQ
18/05	First patients treated with RayCare at Raigmore Hospital	AQ
13/05	RaySearch to showcase groundbreaking innovations at ESTRO 2026	AQ
12/05	First online adaptive treatment on TrueBeam using RayStation and RayCare	AQ
07/05	Bulletin from the Annual General Meeting 2026	AQ
29/04	RaySearch Laboratories : Transcript Q1 2026 (engelska)	PU
29/04	RaySearch Laboratories : Transcript Q1 2026	PU
29/04	Interim report first quarter 2026: Strong long-term performance and raised margin target	AQ
27/04	Institut Hartmann selects RayStation and RayCare	AQ
22/04	Invitation to presentation of RaySearch’s interim report for the first quarter of 2026	AQ
19/04	Günther Mårder resigns from the Board of RaySearch	AQ
17/04	RaySearch receives first RayCare order in China	AQ
15/04	RaySearch Laboratories : Report 2025	PU
15/04	RaySearch publishes Annual Report for 2025	AQ